FI874287A7 - Uudet lymfokiinipeptidit. - Google Patents

Uudet lymfokiinipeptidit. Download PDF

Info

Publication number: FI874287A7
Authority: FI; Finland
Prior art keywords: peptides; novel lymphokine; lymphokine; novel; lymphokine peptides
Prior art date: 1986-10-03

Application number

FI874287A

Other languages

English (en)

Swedish (sv)

Other versions

FI874287A0 (fi

FI874287L (fi

Inventor

Lajos Tarcsay

Karel Gerrit Odink

Roger Clerc

Nico Cerletti

Josef Brueggen

Clemens Sorg

Walter Wiesendanger

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-03

Filing date

1987-09-30

Publication date

1988-04-04

1986-10-03 Priority claimed from GB868623850A external-priority patent/GB8623850D0/en

1986-11-27 Priority claimed from GB868628358A external-priority patent/GB8628358D0/en

1987-09-30 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1987-09-30 Publication of FI874287A0 publication Critical patent/FI874287A0/fi

1988-04-04 Publication of FI874287L publication Critical patent/FI874287L/fi

1988-04-04 Publication of FI874287A7 publication Critical patent/FI874287A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Plant Pathology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Animal Behavior & Ethology (AREA)
Rheumatology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)

FI874287A 1986-10-03 1987-09-30 Uudet lymfokiinipeptidit. FI874287A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868623850A GB8623850D0 (en)	1986-10-03	1986-10-03	Lymphokine related peptide
GB868628358A GB8628358D0 (en)	1986-11-27	1986-11-27	Lymphokine related peptides

Publications (3)

Publication Number	Publication Date
FI874287A0 FI874287A0 (fi)	1987-09-30
FI874287L FI874287L (fi)	1988-04-04
FI874287A7 true FI874287A7 (fi)	1988-04-04

Family

ID=26291377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI874287A FI874287A7 (fi)	1986-10-03	1987-09-30	Uudet lymfokiinipeptidit.

Country Status (11)

Country	Link
US (2)	US5350687A (fi)
EP (1)	EP0263072B1 (fi)
JP (1)	JPH09188698A (fi)
AU (1)	AU7930987A (fi)
DE (1)	DE3789413T2 (fi)
DK (1)	DK517787A (fi)
ES (1)	ES2052602T3 (fi)
FI (1)	FI874287A7 (fi)
IE (1)	IE61773B1 (fi)
NO (1)	NO874159L (fi)
PT (1)	PT85849B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2750604B1 (fr) *	1996-07-02	2002-09-20	Oreal	Heteromere liant l'acide arachidonique et son utilisation en cosmetique ou pharmacie
EP0463037A1 (en) *	1989-03-17	1992-01-02	Genetics Institute, Inc.	Human macrophage migration inhibitory factor
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines
JP2747839B2 (ja) *	1989-08-14	1998-05-06	花王株式会社	モノクローナル抗体
US5149544A (en) *	1989-11-13	1992-09-22	Research Corporation Technologies, Inc.	Method of inhibiting progenitor cell proliferation
SG66214A1 (en) *	1990-09-05	1999-07-20	Heart Research Inst Ltd	Novel chemotactic factor
CH685959A5 (de) *	1992-08-24	1995-11-15	Biomedicals Ag	Diagnostische Testpackung zur Bestimmung von Proteinen.
US6080407A (en) *	1993-05-17	2000-06-27	The Picower Institute For Medical Research	Diagnostic assays for MIF
US5776348A (en) *	1995-02-07	1998-07-07	Massachusetts Institute Of Technology	Mineral precipitation system and method for inhibiting mineral precipitate formation
JP2001509679A (ja)	1997-01-21	2001-07-24	ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド	レセプターをコードするポリヌクレオチドとポリペプチド
EP1118681A1 (en)	1998-09-29	2001-07-25	Asahi Kasei Kabushiki Kaisha	Method for controlling the release of granules
ATE447713T1 (de) *	1998-11-05	2009-11-15	Univ Michigan	S100-proteine und -autoantikörper als serummarker für krebs
UY27304A1 (es)	2001-05-24	2002-12-31	Avanir Pharmaceuticals	Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
WO2003069349A2 (en) *	2002-02-15	2003-08-21	Clemens Sorg	Method for diagnosis of inflammatory diseases using mrp8/mrp14
CA2489860C (en)	2002-07-05	2015-02-10	Universite Laval	Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions
TW200418829A (en)	2003-02-14	2004-10-01	Avanir Pharmaceutics	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US7361474B2 (en) *	2003-02-24	2008-04-22	United States Of America As Represented By The Department Of Veterans Affairs	Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
WO2004084928A1 (en)	2003-03-28	2004-10-07	UNIVERSITé LAVAL	S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
JP2007503388A (ja) *	2003-08-22	2007-02-22	アバニール・ファーマシューティカルズ	マクロファージ遊走阻止因子の阻害剤としての置換ナフチリジン誘導体、およびヒト疾患の治療におけるそれらの使用
CA2557503A1 (en) *	2004-02-25	2005-09-09	The United States Of America, As Represented By The Department Of Vetera Ns Affairs	Methods for diagnosing and treating bladder cancer
SE0400886D0 (sv) *	2004-04-02	2004-04-02	Amersham Biosciences Ab	Process of purification
CA2573596A1 (en) *	2004-07-13	2006-01-19	Universite Laval	S100 protein inhibitors for treating leukemia
KR20070051287A (ko) *	2004-07-23	2007-05-17	아스펜바이오 팜, 인코퍼레이션.	맹장염 진단 방법 및 장치
US7659087B2 (en)	2004-07-23	2010-02-09	Aspenbio Pharma, Inc.	Methods and devices for diagnosis of appendicitis
JP2008534502A (ja)	2005-03-24	2008-08-28	アバニール・ファーマシューティカルズ	マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体
GB0605689D0 (en) *	2006-03-21	2006-05-03	Novartis Ag	Organic compounds
EP2329039B1 (en) *	2008-09-03	2016-05-11	Quantumdx Group Limited	Sensing strategies and methods for nucleic acid detection using biosensors
EP2711682B1 (en)	2011-05-20	2019-07-10	Riken	Clarifying reagent for biological materials and use thereof
US9958456B2 (en)	2011-10-07	2018-05-01	Baxalta Incorporated	OxMIF as a diagnostic marker
WO2016026956A1 (en) *	2014-08-22	2016-02-25	Baxalta GmbH	Detection of cho-mif contaminations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE230876C (fi) *
US4322274A (en) *	1980-08-28	1982-03-30	Wilson Gregory B	Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
GB2125047B (en)	1982-08-09	1986-02-19	Ciba Geigy Ag	Yeast hybrid vectors and their use for the production of polypeptides
GB8318754D0 (en) *	1983-07-11	1983-08-10	Fagerhol M K F	Human proteins anti-sera test kits
JPS6041697A (ja) *	1983-08-15	1985-03-05	Asahi Chem Ind Co Ltd	活性蛋白質誘導体の新規合成法
GR80965B (en)	1983-11-21	1985-03-20	Ciba Geigy Ag	Method for the preparation of protease inhibitors
EP0143081B1 (en)	1983-11-21	1989-08-23	Ciba-Geigy Ag	Synthesis of tissue plasminogen activator(tpa) by yeast
JPH0672158B2 (ja) *	1984-05-24	1994-09-14	チバ−ガイギ− アクチエンゲゼルシヤフト	精製されたヒトマクロファージ遊走阻止因子
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines

1987
- 1987-09-28 EP EP87810561A patent/EP0263072B1/en not_active Expired - Lifetime
- 1987-09-28 DE DE3789413T patent/DE3789413T2/de not_active Expired - Fee Related
- 1987-09-28 ES ES87810561T patent/ES2052602T3/es not_active Expired - Lifetime
- 1987-09-30 FI FI874287A patent/FI874287A7/fi not_active IP Right Cessation
- 1987-10-01 PT PT85849A patent/PT85849B/pt not_active IP Right Cessation
- 1987-10-02 DK DK517787A patent/DK517787A/da not_active Application Discontinuation
- 1987-10-02 AU AU79309/87A patent/AU7930987A/en not_active Abandoned
- 1987-10-02 NO NO874159A patent/NO874159L/no unknown
- 1987-10-02 IE IE264587A patent/IE61773B1/en not_active IP Right Cessation
1990
- 1990-11-21 US US07/617,485 patent/US5350687A/en not_active Expired - Fee Related
1995
- 1995-07-27 US US08/508,142 patent/US5702920A/en not_active Expired - Fee Related
1996
- 1996-12-18 JP JP8338746A patent/JPH09188698A/ja active Pending

Also Published As

Publication number	Publication date
FI874287A0 (fi)	1987-09-30
JPH09188698A (ja)	1997-07-22
FI874287L (fi)	1988-04-04
PT85849B (pt)	1990-07-31
EP0263072A3 (en)	1990-01-10
ES2052602T3 (es)	1994-07-16
DK517787D0 (da)	1987-10-02
EP0263072B1 (en)	1994-03-23
DK517787A (da)	1988-04-04
NO874159L (no)	1988-04-05
AU7930987A (en)	1988-05-19
IE872645L (en)	1988-04-03
US5702920A (en)	1997-12-30
DE3789413T2 (de)	1994-07-28
DE3789413D1 (de)	1994-04-28
IE61773B1 (en)	1994-11-30
PT85849A (en)	1987-11-01
NO874159D0 (no)	1987-10-02
EP0263072A2 (en)	1988-04-06
US5350687A (en)	1994-09-27

Publication	Publication Date	Title
FI874287A7 (fi)	1988-04-04	Uudet lymfokiinipeptidit.
FI873185L (fi)	1988-01-22	Nya peptider.
FI874495L (fi)	1988-04-14	Peptidderivat.
DE3778287D1 (de)	1992-05-21	Peptidische zusammensetzung.
FI873704A0 (fi)	1987-08-26	Nya ksantinderivat.
FI871981A7 (fi)	1987-11-07	Nya dopamin- -hydroxylas-inhibitorer.
FI873193A0 (fi)	1987-07-20	Nya 18-fenylestranderivat.
NO881384L (no)	1988-10-03	Peptider.
NO885108D0 (no)	1988-11-16	Peptider.
FI883257L (fi)	1988-07-07	Nya peptider.
FI873593A0 (fi)	1987-08-20	Nya applikationsformer foer -interferon.
DK354487A (da)	1988-01-12	Oncogen-relaterede peptider
FI872571A0 (fi)	1987-06-09	Nya antracykliner.
FI864626L (fi)	1987-09-08	Rekombinantricintoxin.
FI871094A0 (fi)	1987-03-12	Nya monocykliska estrar.
DE3780388D1 (de)	1992-08-20	Fsh-stimulierendes peptid.
NO872386D0 (no)	1987-06-05	Peptider.
FI872735A0 (fi)	1987-06-18	Nya vacciner.
FI870626A0 (fi)	1987-02-13	Nya polymerbarriaerblandningar.
FI865326A7 (fi)	1988-06-30	Symmetriskt doerrlaos.
FI875130A0 (fi)	1987-11-19	Nya benzokinoliner.
NO883008D0 (no)	1988-07-05	Peptidforbindelser.
DE3774988D1 (de)	1992-01-16	Peptidderivate.
FI870091A0 (fi)	1987-01-12	Nya biocider.
DK91586D0 (da)	1986-02-28	Peptider

Legal Events

Date	Code	Title	Description
2004-08-31	MM	Patent lapsed	Owner name: CIBA-GEIGY AG